High Pointe Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

High Pointe Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-213,690	Closed	-$2.81M	–	187
2014 Q3	$2.81M	Hold	213,690	–	–	1.22%	11
2014 Q2	$3.07M	Hold	213,690	–	–	1.12%	13
2014 Q1	$2.72M	Hold	213,690	–	–	1.05%	20
2013 Q4	$2.14M	Buy	213,690 +102,280	+92%	+$1.16M	0.84%	49
2013 Q3	$1.47M	Buy	111,410 +720	+0.7%	+$9.44K	0.59%	95
2013 Q2	$1.58M	Buy	+110,690	New	+$1.39M	0.69%	90

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

High Pointe Capital Management's NXTM Position: Q4 2014 in Review

High Pointe Capital Management sold out of NxStage Medical Inc. (NXTM) in Q4 2014, closing a stake of 213,690 shares — an estimated $2.81M sold.

High Pointe Capital Management first reported a position in NXTM in Q2 2013 and held it in 6 quarters. The position peaked at $3.07M in Q2 2014. 118 funds tracked by Wall St. Rank hold NXTM as of Q4 2014.

High Pointe Capital Management reported no remaining NxStage Medical Inc. position as of Q4 2014 after selling out during the quarter.
High Pointe Capital Management sold 213,690 NxStage Medical Inc. shares in Q4 2014, an estimated $2.81M.
High Pointe Capital Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 6 quarters.
High Pointe Capital Management's NxStage Medical Inc. position peaked at $3.07M in Q2 2014.
118 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2014.

Based on High Pointe Capital Management's 13F filing for Q4 2014, filed 29 Jan 2015.